Ceapro Raises $466,000 in Non-Brokered Private Placement

EDMONTON, ALBERTA,Private Placement — Ceapro Inc. announced that it has completed a $466,000 private placement. A total of 4,660,000 common shares were issued under the private placement (via private placement memorandum -PPM) at a price of $0.10 each. The common shares are subject to a four-month hold period which expires on October 16, 2009.

Certain directors and officers of Ceapro participated in the private placement and subscribed for and purchased an aggregate of 910,000 common shares.

Ceapro will use the proceeds for sales and marketing, research and development, product and market expansion and for general working capital purposes.

About Ceapro Inc.

Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business activities relate to the development and commercialization of active ingredients using proprietary technology and natural, renewable resources. To learn more about Ceapro, visit www.ceapro.com.
http://www.marketwatch.com/story/ceapro-raises-466000-in-non-brokered-private-placement

About PPM

PPM is the leading U.S. entrepreneurial firm that specializes in writing private placement memorandums (PPM) and linking investors with entrepreneurs.

Since 1999, the founders of PPM have provided professional business writing services, such as a PPM or business plan, to more than 2,000 businesses worldwide. Our company is considered to be the most cost effective, efficient consultants for private placement memorandum development in the United States. We are Wall Street’s, and by extension, the New York private placement (PPM) leaders.

PPM.co’s main service is the creation of private placement memorandum regulation d (Reg. d) documents. However, we offer much more. In case the entrepreneur needs additional services, such as a business plan, website, or additional legal work, PPM can create one pricing package for all required documentation or service. Because we simultaneously work with many companies both in and out of the U.S., the ability to adapt to the individual needs – as well as to regional and global demands – helps our clients save needed capital and time.

We are leaders in:

• Edmonton, Canada Private Placement
• Biotech Private Placement
• Bio Technology Private Placement
• Debt Private Placement
• Equity Private Placement
• Bio Technology Private Placement Memorandum Writing
• Canadian Private Placement Memorandum Writing
• Biotech Private Placement Memorandum Writing
• Debt Private Placement Memorandum Writing
• Equity Private Placement Memorandum Writing